Special 3/2013

  • Intellectual Property

    In this spezial issue:

    • Bio-IP experiencing continental drift
    • Interview with Taros Chemicals "A blueprint for future drug development"
    • Substance Protection - Hands off gene patents!
    • Out-licensing in the life sciences sector

Volume 2014

Volume 2013

Volume 2012

© 2007-2014 BIOCOM

http://www.european-biotechnology-news.com/magazine/spezial/2013/3/pos/1.html?cHash=f5f2e5fdbfbf799a701ac9c5e77ce04b&sort=desc

Kurszettel

Alle Kurse

TOP

  • EVOTEC3.94 EUR8.54%
  • VITA 343.90 EUR4.00%
  • SANTHERA86.50 CHF3.59%

FLOP

  • WILEX2.30 EUR-2.54%
  • 4SC1.22 EUR-2.40%
  • ADDEX3.99 CHF-1.97%

TOP

  • SANTHERA86.50 CHF32.1%
  • BB BIOTECH144.50 EUR9.3%
  • BASILEA103.90 CHF4.4%

FLOP

  • WILEX2.30 EUR-17.9%
  • MOLOGEN7.84 EUR-17.5%
  • 4SC1.22 EUR-14.1%

TOP

  • SANTHERA86.50 CHF3831.8%
  • CO.DON2.57 EUR221.2%
  • PAION2.46 EUR182.8%

FLOP

  • CYTOS0.26 CHF-93.5%
  • MEDIGENE4.55 EUR-66.9%
  • THERAMETRICS0.08 CHF-42.9%

No liability assumed, Date: 27.08.2014